| 标题 |
[求助补充材料]
Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Targeted oncology 作者:Dieras V; Curigliano G; Martin M; Lerebours F; Tsurutani J; et al 出版日期:2026/09/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)